Fundies. English
Segment disclosures
Company overviewEYENOVIA, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
4 dimension combinations 20 retained observations 11 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Ophthalmic Technology Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=eyen:OphthalmicTechnologySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 14720 | Unit_Standard_USD_A63rD4mC5Ei8PKM932gcig | 20250519 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4993 | Unit_Standard_USD_A63rD4mC5Ei8PKM932gcig | 20250519 | Open filing evidence |
Operating Segments · Digital Assets
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hypd:DigitalAssetsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 357693 | Unit_Standard_USD_oo4axWBpWUqESrajFsmrIA | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 601964 | Unit_Standard_USD_oo4axWBpWUqESrajFsmrIA | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 244271 | Unit_Standard_USD_tfBxQyEd9k2Eunxa3h8SKA | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 798735 | Unit_Standard_USD_M4TqV6a0sEWV5tUgoQ51uA | 20260330 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 302506 | Unit_Standard_USD_ruEvontqBEuVPZ29jodjkQ | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 302506 | Unit_Standard_USD_ruEvontqBEuVPZ29jodjkQ | 20251114 | Open filing evidence |
Operating Segments · Ophthalmic Technology Segment
Consolidation Items · Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hypd:OphthalmicTechnologySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 14720 | Unit_Standard_USD_M4TqV6a0sEWV5tUgoQ51uA | 20260330 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 14720 | Unit_Standard_USD_ruEvontqBEuVPZ29jodjkQ | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14720 | Unit_Standard_USD_oo4axWBpWUqESrajFsmrIA | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14720 | Unit_Standard_USD_UPtQrOFkZkeUPzNRcrBhVQ | 20250813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 14720 | Unit_Standard_USD_tfBxQyEd9k2Eunxa3h8SKA | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 57336 | Unit_Standard_USD_M4TqV6a0sEWV5tUgoQ51uA | 20260330 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1625 | Unit_Standard_USD_ruEvontqBEuVPZ29jodjkQ | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 29243 | Unit_Standard_USD_ruEvontqBEuVPZ29jodjkQ | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 22625 | Unit_Standard_USD_UPtQrOFkZkeUPzNRcrBhVQ | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 27618 | Unit_Standard_USD_UPtQrOFkZkeUPzNRcrBhVQ | 20250813 | Open filing evidence |
Ophthalmic Technology Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=eyen:OphthalmicTechnologySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 57336 | Unit_Standard_USD_HkrceMbjfkOd6C2sH8rRrg | 20250415 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3787 | Unit_Standard_USD_HkrceMbjfkOd6C2sH8rRrg | 20250415 | Open filing evidence |